Skip to main content
Erschienen in: Obesity Surgery 4/2016

30.07.2015 | Original Contributions

Preoperative Slow-Release Morphine Reduces Need of Postoperative Analgesics and Shortens Hospital Stay in Laparoscopic Gastric Bypass

verfasst von: Jakob Hedberg, Hanna Zacharias, Lars Janson, Magnus Sundbom

Erschienen in: Obesity Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

As most bariatric procedures are performed by laparoscopy, hospital stay is exceptionally short, despite the habitus of patients and the rather extensive intra-abdominal surgery. To facilitate postoperative mobilization, most patients are given repeated single doses of morphine, a drug with several side effects. We aimed to evaluate the effect of preoperative treatment with a tablet of slow-release morphine (SRM) on postoperative analgesic consumption and length of stay (LOS) in laparoscopic gastric bypass (LGBP).

Methods

The SRM group (244 patients) was retrospectively compared to a control group (197 patients) concerning postoperative pain management and hospital stay by studying medical charts and data from Scandinavian Obesity Surgery Registry (SOReg).

Results

Patients in the SRM group needed significantly less analgesics during days 0, 1, and 2 postoperatively, morphine 10.7 vs. 13.6 mg, 10.2 vs. 13.9 mg, and 1.1 vs. 3.6 mg, respectively, p < 0.05, as well as acetaminophen, p < 0.05. According to a subgroup analysis, 20 mg of SRM was needed to obtain these effects. In addition, SRM patients had shorter hospital stay (2.3 vs. 3.5 days, p < 0.05) than the control group. No negative side effects were seen.

Conclusions

Preoperatively administered slow-release morphine significantly reduced the need for postoperative analgesics and shortened hospital stay, without side effects or other complications. At our department, the studied regime is now routinely used in all bariatric surgery and we have started to use the concept in other groups of surgical patients.
Literatur
2.
Zurück zum Zitat Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2010;21:1407–12.CrossRef Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2010;21:1407–12.CrossRef
3.
Zurück zum Zitat Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36.CrossRefPubMed Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36.CrossRefPubMed
4.
Zurück zum Zitat Andersen LP, Werner MU, Rosenberg J, et al. Analgesic treatment in laparoscopic gastric bypass surgery: a systematic review of randomized trials. Obes Surg. 2014;24:462–70.CrossRefPubMed Andersen LP, Werner MU, Rosenberg J, et al. Analgesic treatment in laparoscopic gastric bypass surgery: a systematic review of randomized trials. Obes Surg. 2014;24:462–70.CrossRefPubMed
5.
Zurück zum Zitat Saurabh S, Smith JK, Pedersen M, et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014. Saurabh S, Smith JK, Pedersen M, et al. Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014.
6.
Zurück zum Zitat Wu R, Haggar F, Porte N, et al. Assessing the feasibility of a randomised, double-blinded, placebo-controlled trial to investigate the role of intraperitoneal ropivacaine in gastric bypass surgery: a protocol. BMJ Open. 2014;4(8):e005823.CrossRefPubMedPubMedCentral Wu R, Haggar F, Porte N, et al. Assessing the feasibility of a randomised, double-blinded, placebo-controlled trial to investigate the role of intraperitoneal ropivacaine in gastric bypass surgery: a protocol. BMJ Open. 2014;4(8):e005823.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Cohen AR, Smith AN, Henriksen BS. Postoperative opioid requirements following Roux-en-Y gastric bypass in patients receiving continuous bupivacaine through a pump system: a retrospective review. Hosp Pharm. 2013;48:479–83.CrossRefPubMedPubMedCentral Cohen AR, Smith AN, Henriksen BS. Postoperative opioid requirements following Roux-en-Y gastric bypass in patients receiving continuous bupivacaine through a pump system: a retrospective review. Hosp Pharm. 2013;48:479–83.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Alimian M, Faiz S, Imani F, et al. Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesthesiol Pain Med. 2012;2:12–26.CrossRef Alimian M, Faiz S, Imani F, et al. Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesthesiol Pain Med. 2012;2:12–26.CrossRef
9.
Zurück zum Zitat Olbers T, Lönroth H, Fagevik-Olsén M, et al. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13:364–70.CrossRefPubMed Olbers T, Lönroth H, Fagevik-Olsén M, et al. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13:364–70.CrossRefPubMed
11.
Zurück zum Zitat Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg. 2004;91:418–23.CrossRefPubMed Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg. 2004;91:418–23.CrossRefPubMed
12.
Zurück zum Zitat Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg. 2001;11:284–92.CrossRefPubMed Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg. 2001;11:284–92.CrossRefPubMed
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed
17.
Zurück zum Zitat Lloret-Linares C, Lopes A, Declèves X, et al. Challenges in the optimization of post-operative pain management with opioids in obese patients: a literature review. Obes Surg. 2013;23:1458–75.CrossRefPubMed Lloret-Linares C, Lopes A, Declèves X, et al. Challenges in the optimization of post-operative pain management with opioids in obese patients: a literature review. Obes Surg. 2013;23:1458–75.CrossRefPubMed
18.
Zurück zum Zitat Menzo EL, Szomstein S, Rosenthal RJ. Changing trends in bariatric surgery. Scand J Surg. 2015;104:18–23.CrossRefPubMed Menzo EL, Szomstein S, Rosenthal RJ. Changing trends in bariatric surgery. Scand J Surg. 2015;104:18–23.CrossRefPubMed
19.
Zurück zum Zitat Tan M, Law LS, Gan T. Optimizing pain management to facilitate enhanced recovery after surgery pathways. Can J Anesth. 2015;62:203–18.CrossRefPubMed Tan M, Law LS, Gan T. Optimizing pain management to facilitate enhanced recovery after surgery pathways. Can J Anesth. 2015;62:203–18.CrossRefPubMed
20.
Zurück zum Zitat Barreca M, Renzi C, Tankel J, et al. Is there a role for enhanced recovery after laparoscopic bariatric surgery? Preliminary results from a specialist obesity treatment center. Surg Obes Relat Dis. 2015. Barreca M, Renzi C, Tankel J, et al. Is there a role for enhanced recovery after laparoscopic bariatric surgery? Preliminary results from a specialist obesity treatment center. Surg Obes Relat Dis. 2015.
21.
Zurück zum Zitat Waydia S, Gunawardene A, Gilbert J, et al. 23-hour/next day discharge post-laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery is safe. Obes Surg. 2014;24:2007–10.CrossRefPubMed Waydia S, Gunawardene A, Gilbert J, et al. 23-hour/next day discharge post-laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery is safe. Obes Surg. 2014;24:2007–10.CrossRefPubMed
22.
Zurück zum Zitat Carter J, Elliott S, Kaplan J, et al. Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the national surgical quality improvement program. Surg Obes Relat Dis. 2015;11:288–94.CrossRefPubMed Carter J, Elliott S, Kaplan J, et al. Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the national surgical quality improvement program. Surg Obes Relat Dis. 2015;11:288–94.CrossRefPubMed
23.
Zurück zum Zitat Elliott JA, Patel VM, Kirresh A, et al. Fast-track laparoscopic bariatric surgery: a systematic review. Updat Surg. 2013;65:85–94.CrossRef Elliott JA, Patel VM, Kirresh A, et al. Fast-track laparoscopic bariatric surgery: a systematic review. Updat Surg. 2013;65:85–94.CrossRef
24.
Zurück zum Zitat Jensen-Otsu E, Ward EK, Mitchell B, et al. The effect of Medicaid status on weight loss, hospital length of stay, and 30-day readmission after laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2015;25:295–301.CrossRefPubMed Jensen-Otsu E, Ward EK, Mitchell B, et al. The effect of Medicaid status on weight loss, hospital length of stay, and 30-day readmission after laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2015;25:295–301.CrossRefPubMed
Metadaten
Titel
Preoperative Slow-Release Morphine Reduces Need of Postoperative Analgesics and Shortens Hospital Stay in Laparoscopic Gastric Bypass
verfasst von
Jakob Hedberg
Hanna Zacharias
Lars Janson
Magnus Sundbom
Publikationsdatum
30.07.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 4/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1817-1

Weitere Artikel der Ausgabe 4/2016

Obesity Surgery 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.